Sign inJoin waitlistJoin the waitlist

IR

Ian Rabinowitz

Physician · University of New Mexico School of Medicine

Credentials: · ·

History

University of New Mexico School of Medicine · Gila Regional Medical Center
2019–Present

Hematology and Medical Oncology
Washington University School of Medicine
1989–1992
Internal Medicine
Vanderbilt University Medical Center
1986–1989
Johannesburg Hospital
1984–1985
University of Witwatersrand, Johannesberg, South Africa (1984), Internal Medicine
1980–1984

Research

First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers
Journal of Clinical Oncology · 2019 · 484 citations
Accuracy of radiation field alignment in clinical practice
International journal of radiation oncology · 1985 · First of 5 authors · 228 citations
Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer
Clinical Cancer Research · 2010 · 134 citations

Claire Verschraegen
8 papers
JS
J Sadler
5 papers
Thèrése Bocklage
5 papers
FL
Fa Lee
4 papers
MF
Mohammad Fekrazad
4 papers
EL
Edward Libby
3 papers
Hamid Sayar
3 papers
HS
Harriet Smith
3 papers
MR
Melanie Royce
3 papers
AM
Aroop Mangalik
2 papers
DQ
Dulcinea Quintana
2 papers
Joshua Hanson
2 papers

Grants

University of New Mexico Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $267.2K · University of New Mexico Health Scis Ctr
2005–2015

Clinical trials

Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Principal investigator · Terminated · Phase 1
New Mexico Cancer Research Alliance
2014–2015
A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)
Principal investigator · Withdrawn · Phase 2
New Mexico Cancer Research Alliance
2009–2010
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
Principal investigator · Completed
New Mexico Cancer Research Alliance
2004–2006
Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2004